We discovered a strong associated between SNHG7 expression and race, residual tumor, OS, and DSS of COAD patients, with SNHG7 expression appearing to be higher in patients with certain characteristics, such as specific race and with residual tumor. This evidence concerns the gene SNHG7 and neoplasm.